CALINA, NCT04300309: Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria |
|
|
| Terminated | 2/3 | 28 | RoW | artemether:lumefantrine (2.5 mg:30 mg) | Novartis Pharmaceuticals, European and Developing Countries Clinical Trials Partnership (EDCTP), Medicines for Malaria Venture (MMV), Switzerland, Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso, Institut de Recherche en sciences de la Santé - Unité de Recherche Clinique de Nanoro (IRSS-URCN), Burkina Faso | Plasmodium Falciparum Malaria | 07/23 | 05/24 | | |
